Texas Invokana Kidney Damage Attorney


The Dr Shezad Malik Law Firm is currently accepting Invokana injury cases nationwide, including California, Florida, Illinois, New York and Texas.

Invokana Kidney DamageIf you or somebody you know was diagnosed with diabetic ketoacidosis, or kidney failure after using Invokana, you should contact our attorneys immediately for a free case consultation.

Please use the form to contact our Defective Drug Litigation Team or call us toll-free 24 hours a day at (888) 210-9693 ext. 2 or 214-390-3189.

Invokana is a Diabetic Medication

Johnson & Johnson’s Janssen Pharmaceuticals unit manufactures and distributes Invokana (canagliflozin), for folks with type-2 diabetes, to control their blood-sugar levels.

Invokana Mechanism of Action

The FDA approved Invokana in 2013, and Invokana was the first medication in a new class known as sodium-glucose cotransporter-2 (SGLT2) inhibitors.

Other members of this class include Farxiga, Invokamet, Glyxambi, Jardiance, and Xigduo XR.

Invokana is the most widely used of the class. These medications prevent hyperglycemia (high blood-sugar levels) by allowing the kidneys remove excess blood sugar via the urine.

What is the problem with Invokana?

According to a report from the Institute for Safe Medication Practices (ISMP), Invokana has been linked to hundreds of severe adverse events.

The FDA has received over 457 adverse events for Invokana in its first 12 months on the market, including:

  • Kidney failure or damage
  • Kidney stones
  • Fluid/electrolyte problems
  • Urinary tract infections
FDA Warning: Invokana Linked to Diabetic Ketoacidosis

In May 2015, the FDA issued a Safety Communication for all drugs in the SGLT2 inhibitor class, including Invokana, after receiving 20 reports of patients who developed diabetic ketoacidosis.

All of the victims were hospitalized between March 2013 and June 2014. The FDA has continued to receive more reports of this side effect.

New warning labels will be required for Invokana, Invokamet, Farxiga, Glyxambi, Jardiance, and Xigduo XR, which urge patients to look for signs of the DKA condition and to seek immediate medical attention if symptoms are present.

EMA Warning: 101 Cases of Ketoacidosis Reported Worldwide

According to the European Medicines Agency (EMA) warning issued in June 2015, SLGT2 inhibitor diabetes drugs have been associated with 101 cases of diabetic ketoacidosis worldwide.

What is Diabetic Ketoacidosis?

Diabetic ketoacidosis (DKA) is a serious complication of diabetes that occurs when the body produces high levels of blood ketones.

DKA develops when the body is unable to produce enough insulin. Insulin plays a key role in helping sugar (glucose) — a major source of energy for the muscles and other tissues — enter the cells.

Without enough insulin, the body begins to break down fat as an alternate fuel source. This process produces a buildup of toxic acids in the bloodstream called ketones, eventually leading to diabetic ketoacidosis if untreated.

What are Diabetic Ketoacidosis Symptoms?
  • Decreased alertness
  • Deep, rapid breathing
  • Dry skin and mouth
  • Flushed face
  • Frequent urination or thirst that lasts a day or more
  • Fruity-smelling breath
  • Headache
  • Muscle stiffness or aches
  • Nausea and vomiting
  • Stomach pain
Developed Invokana Diabetic Ketoacidosis?

The Dr Shezad Malik Law Firm is currently accepting Invokana injury cases nationwide, including California, Florida, Illinois, New York and Texas.

If you or somebody you know was diagnosed with diabetic ketoacidosis, or kidney failure after using Invokana, you should contact our attorneys immediately for a free case consultation. Please use the form to contact our Defective Drug Litigation Team or call us toll-free 24 hours a day at (888) 210-9693 ext. 2.

Our law firm’s principal office is in Dallas and we have offices in Fort Worth, Texas. Dr Shezad Malik Law Firm represents clients in dangerous drug and dangerous medical device lawsuits nationwide.

CONTACT US FOR A FREE INITIAL CONSULTATION
Contact Us